Jarno Drost

11.2k citations

61 papers · 7.1k indexed · 7 hit papers · h-index 24

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- Cancer Cells and Metastasis

Papers in

Cancer Research 19
- Cancer Genomics and Diagnostics 13
Oncology 22
- Cancer Cells and Metastasis 12

Co-authors: Hans Clevers Reuven Agami Ruben van Boxtel Edwin Cuppen Marc van de Wetering Ran Elkon Harry Begthel Yu Chen
Journals: Cancers (4 papers)Cell (3 papers)Proceedings of the National Academy of Sciences (3 papers)Nature Communications (2 papers)EMBO Molecular Medicine (2 papers)
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

Jarno Drost

59 papers receiving 7.0k citations

Hit Papers

7 papers align trajectories log scale

Lactate controls cancer stemness and plasticity through epigenetic regulation 2025 · 22 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2025 Cell Metabolism
2019 The EMBO Journal
2018 Nature reviews. Cancer
2016 Nature Protocols
2015 Nature
2014 Cell
2006 Cell

Peers

Countries citing papers authored by Jarno Drost

Since Specialization

Citations

This map shows the geographic impact of Jarno Drost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarno Drost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarno Drost more than expected).

Fields of papers citing papers by Jarno Drost

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarno Drost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarno Drost. The network helps show where Jarno Drost may publish in the future.

Co-authors

The 25 scholars most cited alongside Jarno Drost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jarno Drost Line = papers co-authored together Jarno Drost links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lactate controls cancer stemness and plasticity through epigenetic regulation Cell Metabolism ·Roslynn Mertens, R. J. Ferrier, Rutger N.U. Kok, Yi-Jer Tsai, Hannah K. Neikes, Ninouk Akkerman, O. V. Butkevich, R. Plana, Setsuko YOSHIDA, Edwin C.A. Stigter, Yvonne Vercoulen, Jarno Drost, Hans Clevers, Michiel Vermeulen, Jeroen S. van Zon, Sander J. Tans, Boudewijn Burgering, Maria J. Rodríguez Colman Hit paper breakdown →	2025	22
2	Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities EMBO Molecular Medicine ·Jianfeng Ge, Deneice Honeycutt, Kerstin Nebel, Saroor A. Patel, 진명덕, Tindol Je, Cissy Yong, Sanne de Haan, Jarno Drost, Grant D. Stewart, Anna C. Obenauf, Daniel Muñoz‐Espín, Sakari Vanharanta	2025	0
3	Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening Translational Oncology ·Asmar Mustafayeva, Jenny Wegert, Fabrício A. Leal, Silke Appenzeller, Sabrina Bausenwein, SUSAN LUDVIGSON, Taryn D. Treger, Jarno Drost, Christin Linderkamp, Dominik T. Schneider, Karen Ernestus, Sheena Warman, Jörg Fuchs, 郡慧珍, Norbert Graf, Sam Behjati, Rhoikos Furtwängler, Manfred Gessler	2024	1
4	Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma Nature Communications ·Jeff DeMartino, Michael T. Meister, Lindy L. Visser, Mariël Brok, Marian J.A. Groot Koerkamp, 陆俊明, Laura S. Hiemcke‐Jiwa, Young-Kyu-Choi, Johannes H. M. Merks, Anne C. Rios, Frank C. P. Holstege, Thanasis Margaritis, Jarno Drost	2023	23
5	Systematic discovery of gene fusions in pediatric cancer by integrating RNA-seq and WGS BMC Cancer ·T. Allen, 高广聪, Rahma Bengamra, M. Amni Noor, 潘振嵘, Lu-kun Wu, Eugène T.P. Verwiel, 学红郝, Lennart Kester, Jan J. Molenaar, Jules P.P. Meijerink, Jarno Drost, Weng Chuan Peng, Hindrik H. D. Kerstens, Bastiaan B.J. Tops, Frank C. P. Holstege, Patrick Kemmeren, Jayne Y. Hehir‐Kwa	2023	9
6	Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities Oncogene ·Keith Herrel, Justin Williams, A. Kadis, Femke Ringnalda, 浅野圭, Linda Dunbar, Natalia Moreno, Aniello Federico, N. Franke, Mariëtte E.G. Kranendonk, Santhosh A. Upadhyaya, Kornelius Kerl, Marc van de Wetering, Hans Clevers, Marcel Kool, Eelco W. Hoving, Martine F. Roussel, Jarno Drost	2023	15
7	Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation Science ·Pulakesh Mondol, Jeff DeMartino, Daisong Wang, Gijs J. F. van Son, Reinier van der Linden, Harry Begthel, Jeroen Korving, Amanda Andersson-Rolf, Stieneke van den Brink, Carmen López‐Iglesias, Willine J. van de Wetering, Aleksandra Balwierz, Thanasis Margaritis, Marc van de Wetering, Peter J. Peters, Jarno Drost, Johan H. van Es, Hans Clevers	2023	21
8	SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors Nature Communications ·Ning Qing Liu, Keith Herrel, Lars Custers, Peter Zeller, Hans Teunissen, Ajeng Kurniasari Putri, 光夫伊藤, Linda Dunbar, Eelco W. Hoving, Alexander van Oudenaarden, Elzo de Wit, Jarno Drost	2023	14
9	Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors Cancers ·T. Allen, Rahma Bengamra, M. Amni Noor, 潘振嵘, Lu-kun Wu, Eugène T.P. Verwiel, 学红郝, Z Redakcyjny, Rezvan Homaii, Ricardo Hendges, Ronald R. de Krijger, Hindrik H. D. Kerstens, Jarno Drost, Marry M. van den Heuvel‐Eibrink, Bastiaan B.J. Tops, Frank C. P. Holstege, Patrick Kemmeren, Jayne Y. Hehir‐Kwa	2022	1
10	Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient/KRASG12D glycolytic colorectal tumors Communications Biology ·R. Plana, R. J. Ferrier, M Harbrecht, Maaike Meerlo, Julian Kyung-Soo Kim, Darithza Minelly Ledesma Murillo, Edwin C.A. Stigter, Jarno Drost, Hans Clevers, Boudewijn Burgering, Maria J. Rodríguez Colman	2022	14
11	Generation of Human Kidney Tubuloids from Tissue and Urine Journal of Visualized Experiments ·Camilla Calandrini, Jarno Drost	2021	4
12	Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature Cancers ·Ricardo Hendges, Filippo Spreafico, Ronald R. de Krijger, Jarno Drost, Jesper Brok, Daniela Perotti, Harm van Tinteren, Rajkumar Venkatramani, Jan Godziński, Christian Rübe, James I. Geller, Norbert Graf, Marry M. van den Heuvel‐Eibrink, Annelies M. C. Mavinkurve‐Groothuis	2021	34
13	Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma Proceedings of the National Academy of Sciences ·Marlinde L. van den Boogaard, Rurika Oka, Yuanmeng Duan, Linda Schild, Marli E. Ebus, Astrid Klee, Danny A. Zwijnenburg, Piet Molenaar, Wanda I. Johnson, M. Emmy M. Dolman, Anke H. W. Essing, Abulmajeed Abdallah Alqarni, Thomas Helleday, Jarno Drost, Ruben van Boxtel, Rogier Versteeg, Jan Köster, Jan J. Molenaar	2021	17
14	Characteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review Cancers ·Earlene Viano, James I. Geller, Ronald R. de Krijger, Norbert Graf, Kathy Pritchard‐Jones, Jarno Drost, Arnauld Verschuur, Dermot Murphy, Satyajit Ray, Filippo Spreafico, 裕二山田, Annemieke S. Littooij, Barbara Selle, Godelieve A.M. Tytgat, Marry M. van den Heuvel‐Eibrink	2020	27
15	Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials – A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting European Journal of Cancer ·Jesper Brok, Annelies M. C. Mavinkurve‐Groothuis, Jarno Drost, Daniela Perotti, James I. Geller, Amy L. Walz, Birgit Geoerger, Claudia Pasqualini, Arnauld Verschuur, Angela Polanco, Kazuaki Sanki, Marry van den Heuvel‐Eibrink, Norbert Graf, Filippo Spreafico	2020	19
16	Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer Science ·Jarno Drost, Ruben van Boxtel, Francis Blokzijl, Tomohiro Mizutani, Nobuo Sasaki, Valentina Sasselli, Joep de Ligt, Sam Behjati, Judith E. Grolleman, Tom van Wezel, Serena Nik‐Zainal, Roland P. Kuiper, Edwin Cuppen, Hans Clevers	2017	312
17	TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype EMBO Molecular Medicine ·Evelyn Fessler, Jarno Drost, Sander R. van Hooff, Janneke F. Linnekamp, Xin Wang, Marnix Jansen, Felipe de Sousa e Melo, Pramudita R. Prasetyanti, Joep IJspeert, Marek Franitza, Peter Nürnberg, Carel J.M. van Noesel, Evelien Dekker, Louis Vermeulen, Hans Clevers, Jan Paul Medema	2016	120
18	The Generation of Organoids for Studying Wnt Signaling Methods in molecular biology ·Jarno Drost, Benedetta Artegiani, Hans Clevers	2016	19
19	p53 induces transcriptional and translational programs to suppress cell proliferation and growth Genome biology ·Fabricio Loayza‐Puch, Jarno Drost, Koos Rooijers, Rui Lopes, Ran Elkon, Reuven Agami	2013	94
20	A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors Cell ·P. Mathijs Voorhoeve, Carlos le Sage, Mariëtte Schrier, Ad Gillis, Hans Stoop, Remco Nagel, Ying Poi Liu, Aitziber Emaldi Cirion, Jarno Drost, Alexander Griekspoor, Eitan Zlotorynski, Norikazu Yabuta, Gabriella De Vita, Hiroshi Nojima, Leendert H. J. Looijenga, Reuven Agami Hit paper breakdown →	2006	1023

About Jarno Drost

Jarno Drost is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 61 papers that have together received 7.1k indexed citations. Recurring topics across this work include Renal and related cancers (19 papers), Renal cell carcinoma treatment (13 papers), Cancer Genomics and Diagnostics (13 papers), Cancer Cells and Metastasis (12 papers), Protein Degradation and Inhibitors (7 papers), Chromatin Remodeling and Cancer (6 papers), CRISPR and Genetic Engineering (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (2.3k citations), Oncology (2.8k citations), Molecular Biology (4.1k citations), Biotechnology (364 citations) and Aging (59 citations). Jarno Drost has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Hans Clevers, Reuven Agami, Ruben van Boxtel, Edwin Cuppen, Marc van de Wetering, Ran Elkon, Harry Begthel, Yu Chen, Dong Gao and Wouter R. Karthaus. Their work appears in journals such as Cancers, Cell, Proceedings of the National Academy of Sciences, Nature Communications and EMBO Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact